These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 20575634)

  • 21. Local cutaneous necrosis secondary to a prolonged peripheral infusion of methylene blue in vasodilatory shock.
    Dumbarton TC; Gorman SK; Minor S; Loubani O; White F; Green R
    Ann Pharmacother; 2012 Mar; 46(3):e6. PubMed ID: 22388329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion.
    Wolin MS; Cherry PD; Rodenburg JM; Messina EJ; Kaley G
    J Pharmacol Exp Ther; 1990 Sep; 254(3):872-6. PubMed ID: 2168487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Bakker J; Grover R; McLuckie A; Holzapfel L; Andersson J; Lodato R; Watson D; Grossman S; Donaldson J; Takala J;
    Crit Care Med; 2004 Jan; 32(1):1-12. PubMed ID: 14707554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of methylene blue in addition to norepinephrine on the intestinal microcirculation in experimental septic shock.
    Nantais J; Dumbarton TC; Farah N; Maxan A; Zhou J; Minor S; Lehmann C
    Clin Hemorheol Microcirc; 2014; 58(1):97-105. PubMed ID: 25227191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: A Narrative Review.
    Puntillo F; Giglio M; Pasqualucci A; Brienza N; Paladini A; Varrassi G
    Adv Ther; 2020 Sep; 37(9):3692-3706. PubMed ID: 32705530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
    Wilson SJ; Mehta SS; Bellamy MC
    Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL; Walley KR
    Curr Opin Crit Care; 2009 Oct; 15(5):398-402. PubMed ID: 19542884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
    Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
    Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
    Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of methylene blue in septic shock: pros and cons.
    Arias-Ortiz J; Vincent JL
    Crit Care; 2024 Feb; 28(1):46. PubMed ID: 38365828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glibenclamide dose response in patients with septic shock: effects on norepinephrine requirements, cardiopulmonary performance, and global oxygen transport.
    Morelli A; Lange M; Ertmer C; Broeking K; Van Aken H; Orecchioni A; Rocco M; Bachetoni A; Traber DL; Landoni G; Pietropaoli P; Westphal M
    Shock; 2007 Nov; 28(5):530-5. PubMed ID: 17589379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin and methylene blue: alternate therapies in vasodilatory shock.
    Lavigne D
    Semin Cardiothorac Vasc Anesth; 2010 Sep; 14(3):186-9. PubMed ID: 20705641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Septic shock and NO].
    Mitaka C
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():540-3. PubMed ID: 15506445
    [No Abstract]   [Full Text] [Related]  

  • 35. [Research progress of methylene blue in the treatment of sepsis and septic shock].
    Xue J; Lou X; Chen G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1384-1387. PubMed ID: 34980315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in Hemodynamics After Methylene Blue Administration in Drug-Induced Vasodilatory Shock: A Case Report.
    Laes JR; Williams DM; Cole JB
    J Med Toxicol; 2015 Dec; 11(4):460-3. PubMed ID: 26310944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blue dye, green heart.
    Tan CD; Rodriguez ER
    Cardiovasc Pathol; 2010; 19(2):125-6. PubMed ID: 18703358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD; Jung R; Fish DN; MacLaren R
    Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of corticosteroids in septic shock.
    Burry LD; Wax RS
    Ann Pharmacother; 2004 Mar; 38(3):464-72. PubMed ID: 14970369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The soluble guanylate cyclase inhibitor methylene blue evokes preterm delivery and fetal growth restriction in a mouse model.
    Tiboni GM; Giampietro F; Lamonaca D
    In Vivo; 2001; 15(4):333-7. PubMed ID: 11695226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.